Most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term, according to a new study reported in JAMA Network Open.
Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick.
LONDON — No blanket statement could be made regarding whether patients undergoing noncardiac surgery should continue or withdraw their renin-angiotensin system (RAS) inhibitor therapy based
September 1, 2024